Intense Blood Pressure Lowering Benefit Confirmed in Diabetes
For patients with diabetes, a systolic target of 120 mm Hg led to a significant reduction in CV events in BPROADS, mirroring results from SPRINT in patients without diabetes.
Medscape Medical News
source https://www.medscape.com/viewarticle/intense-blood-pressure-lowering-benefit-confirmed-diabetes-2024a1000kxa?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/intense-blood-pressure-lowering-benefit-confirmed-diabetes-2024a1000kxa?src=rss
Comments
Post a Comment